Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease

Sodium selenite supplementation increases GPx-1 activity in endothelial cells and in CAD patients. Future studies have to demonstrate whether long-term CAD outcome can be improved.